Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po

Možnosti:
  Ponastavi


Iskalni niz: "avtor" (Maja Primic-Žakelj) .

1 - 10 / 184
Na začetekNa prejšnjo stran12345678910Na naslednjo stranNa konec
1.
Cancer burden in Slovenia with the time trends analysis
Vesna Zadnik, Maja Primic-Žakelj, Katarina Lokar, Katja Jarm, Urška Ivanuš, Tina Žagar, 2017, izvirni znanstveni članek

Povzetek: Background The aim of our study was to describe cancer burden and time trends of all cancers combined, the most frequent as well as the rare cancers in Slovenia. Patients and methods The principal data source was the population-based Cancer Registry of Republic of Slovenia. The cancer burden is presented by incidence and prevalence for the period 1950%2013 and by mortality for years 1985%2013. The time trends were characterized in terms of an average annual percent change estimated by the log-linear joinpoint regression. The Dyba-Hakulinen method was used for estimation of incidence in 2016 and the projections of cancer incidence for the year 2025 were calculated applying the Globocan projection software. Results In recent years, near 14,000 Slovenes were diagnosed with cancer per year and just over 6,000 died; more than 94,000 people who were ever diagnosed with cancer are currently living among us. The total burden of cancer is dominated by five most common cancer sites: skin (non-melanoma), colon and rectum, lung, breast and prostate, together representing almost 60% of all new cancer cases. On average the incidence of common cancers in Slovenia is increasing for 3.0% per year in last decade, but the incidence of rare cancers is stable. Conclusions Because cancer occurs more among the elderly, and additionally more numerous post-war generation is entering this age group, it is expected that the burden of this disease will be growing further, even if the level of risk factors remains the same as today.
Ključne besede: cancer burden, cancer registry, incidence, prevalence
Objavljeno v DiRROS: 24.05.2024; Ogledov: 81; Prenosov: 60
.pdf Celotno besedilo (557,44 KB)
Gradivo ima več datotek! Več...

2.
Microinvasive cervical squamous cell carcinoma in Slovenia during the period 2001-2007
Helena Gutnik, Jasenka P. Matišić, Maja Primic-Žakelj, Margareta Strojan Fležar, 2014, izvirni znanstveni članek

Povzetek: Background. Microinvasive squamous cell carcinoma (MISCC) comprises a significant portion of all cervical cancers in Slovenia. Criteria of carcinomatous invasion are well described in the literature, however histopathological assessment of MISCC is difficult, because morphological characteristics can overlap with cervical intraepithelial neoplasia grade 3 (CIN 3) and other pathological changes. The aim of our study was to evaluate the reliability of the histopathological diagnosis of MISCC in Slovenia during the period from 2001 to 2007. Materials and methods. Data on patients with a histopathological diagnosis of cervical MISCC (FIGO stage IA) in the period of 2001 to 2007 were obtained from the Cancer Registry of Slovenia. Histological slides were obtained from the majority of pathology laboratories in Slovenia. We received 250 cases (69% of all MISCC) for the review; 30 control cases with CIN 3 and invasive squamous cell carcinoma FIGO stage IB were intermixed. The slides were coded and reviewed. Results. Among 250 cases originally diagnosed as MISCC, there was an agreement with MISCC diagnosis in 184 (73.6%) cases (of these 179/184 (97.3%) cases were FIGO stage IA1 and 5/184 (2.7%) cases were FIGO stage IA2). Among 179 FIGO stage IA1 cases 117 (65.4%) showed only early stromal invasion. Conclusions. The retrospective review of cases diagnosed as MISCC during the period 2001- 2007 in Slovenia showed a considerable number of overdiagnosed cases. Amongst cases with MISCC confirmed on review, there was a significant proportion with early stromal invasion (depth of invasion less than 1 mm).
Ključne besede: cervical cancer, cervical squamous cell carcinoma, microinvasive squamous cell carcinoma, intraepithelial neoplasia
Objavljeno v DiRROS: 11.04.2024; Ogledov: 373; Prenosov: 257
.pdf Celotno besedilo (969,61 KB)

3.
Complete yearly life tables by sex for Slovenia, 1982-2004, and their use in public health
Tina Žagar, Vesna Zadnik, Maja Pohar Perme, Maja Primic-Žakelj, 2006, izvirni znanstveni članek

Objavljeno v DiRROS: 15.02.2024; Ogledov: 146; Prenosov: 34
.pdf Celotno besedilo (1,84 MB)

4.
Can we rely on cancer mortality data? Checking the validity of cervical cancer mortality data for Slovenia
Maja Primic-Žakelj, Vera Pompe-Kirn, Fani Škrlec, Jožica Šelb-Šemerl, 2001, izvirni znanstveni članek

Povzetek: Background. Valid inference on cervical cancer mortality is very difficult since - on the basis of death certificates - it is not always possible to distinguish between cervix, corpus and unspecified uterine cancer deaths. Our aim was to estimate the extent to which cervical cancer as the official cause of death reflects the true mortality from cervical cancer in Slovenia. Material and methods. The data on 2245 deaths from cervix, corpus uteri, and uterus-unspecified cancers for the period 1985-1999 were linked to the Cancer Registry of Slovenia database from the mortality database of Slovenia. Results. Officially, in the period 1985-1999, there were 878 cervical cancer deaths. The comparison of these causes of death with the cancer sites registered in the Cancer Registry revealed that they include only 87.7 % patients with a previous diagnosis of cervical cancer. Of 650 corpus uteri cancer deaths, 17.1% of patients were registered to have cervical cancer, and of 717 unspecified uterine cancer deaths, 31.4% were registered. Taking into account the correctly identified cervical cancer cases among cervical cancer deaths and misclassified cervical cancer deaths as corpus uteri and unspecified uterine, the corrected number of deaths would be 1106. Conclusions. When evaluating the impact of cervical cancer mortality from national mortality rates, the stated underestimation should be taken into account. However, this does not hold for some other cancers.
Objavljeno v DiRROS: 26.01.2024; Ogledov: 185; Prenosov: 50
.pdf Celotno besedilo (199,95 KB)

5.
European code against cancer
P... Boyle, Maja Primic-Žakelj, 1995, poljudni članek

Objavljeno v DiRROS: 15.01.2024; Ogledov: 204; Prenosov: 59
.pdf Celotno besedilo (94,96 KB)

6.
European code against cancer
Peter Boyle, Maja Primic-Žakelj, 1995, ni določena

Ključne besede: rak (medicina), preventiva, Evropa
Objavljeno v DiRROS: 15.01.2024; Ogledov: 217; Prenosov: 70
.pdf Celotno besedilo (94,96 KB)

7.
Epidemiological features of lung cancer in Slovenia
Vera Pompe-Kirn, Maja Primic-Žakelj, Neva Volk, 1994, strokovni članek

Ključne besede: rak (medicina), Slovenija, epidemiologija, pljuča, pljučni rak
Objavljeno v DiRROS: 11.01.2024; Ogledov: 240; Prenosov: 65
.pdf Celotno besedilo (777,07 KB)

8.
Etiology and primary cancer prevention
Maja Primic-Žakelj, 1993, izvirni znanstveni članek

Ključne besede: rak (medicina), karcinom, etiologija, preventiva
Objavljeno v DiRROS: 10.01.2024; Ogledov: 170; Prenosov: 43
.pdf Celotno besedilo (537,68 KB)

9.
Epidemiologija malignega melanoma
Maja Primic-Žakelj, Tina Žagar, Vesna Zadnik, 2007, objavljeni znanstveni prispevek na konferenci

Objavljeno v DiRROS: 06.12.2023; Ogledov: 222; Prenosov: 59
.pdf Celotno besedilo (1,20 MB)

10.
Vloga in delovanje preventivnih/presejalnih centrov za dojke
Jožica Maučec Zakotnik, Mateja Krajc, Maja Primic-Žakelj, 2006, strokovni članek

Objavljeno v DiRROS: 05.12.2023; Ogledov: 190; Prenosov: 60
.pdf Celotno besedilo (584,86 KB)

Iskanje izvedeno v 0.36 sek.
Na vrh